✦ LIBER ✦

Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma

✍ Scribed by Kevin B. Kim; Wen-Jen Hwu; Nicholas E. Papadopoulos; Agop Y. Bedikian; Luis H. Camacho; Chaan Ng; Ingrid M. Hernandez; Angela M. Frost; Monica A. Jack; Patrick Hwu

Publisher: Springer
Year: 2008
Tongue: English
Weight: 268 KB
Volume: 64
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0861-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Temozolomide in combination with interfe

Temozolomide in combination with interferon α-2b in patients with metastatic melanoma : A Phase I dose-escalation study

✍ Sanjiv S. Agarwala; John M. Kirkwood 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract ## BACKGROUND Metastatic melanoma (MM) is associated with a high risk of central nervous system (CNS) metastases, and current chemotherapy does not adequately treat or protect patients with MM against CNS metastases. Therefore, the authors initiated a Phase I study to determine the pha

Phase II study of docetaxel and cisplati

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer

✍ Keon Woo Park; Jin Seok Ahn; Young Suk Park; Jeeyun Lee; Jung Hoon Kang; Joon Oh 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 223 KB

Phase II study of S-1, docetaxel and cis

Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer

✍ Yasushi Sato; Tetsuji Takayama; Tamotsu Sagawa; Yasuo Takahashi; Hiroyuki Ohnuma 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 187 KB

A Phase I and pharmacokinetic study of h

A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

✍ Edward F. McClay; Mary-Eileen T. McClay; Jeffery A. Jones; Paul J. Winski; Rando 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

by 40 mg to the MTD in groups of 3 patients. DDP (80 mg/m 2 ) was begun on Day ogy/Oncology, Hollings Cancer Center, Medical 2 and repeated weekly for a total of 3 weeks. During Week 4, the patients were University of South Carolina, Charleston, South not treated with DDP but instead evaluated for r

Phase 2 trial of combination thalidomide

Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508

✍ Joseph I. Clark; James Moon; Laura F. Hutchins; Jeffrey A. Sosman; W. Martin Kas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

A phase I study of gemcitabine and docet

A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors

✍ David P. Ryan; Thomas J. Lynch; Michael L. Grossbard; Michael V. Seiden; Charles 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

A Phase I study was initiated to determine the maximum tolerated dose of weekly gemcitabine combined with monthly, fixed-dose docetaxel. ## METHODS. Patients with metastatic solid tumors were treated with docetaxel, 60 mg/m 2 , on Day 1 every 28 days. Gemcitabine was administered on Days 1, 8, and